Bayer HealthCare Co., Ltd., Daying-35, ethinyl estradiol cyproterone tablets, the top ten brands of contraceptives, began in 1863, belongs to the German Bayer Group, well-known oral short-acting contraceptives, can also treat nodular-forming acne/androgenetic alopecia in women/mild hirsutism

Daying-35 (ethinylestradiol cyproterone tablets), indicated for ethinylestradiol cyproterone tablets, can be used for oral contraception. Ethinylestradiol cyproterone tablets are also used to treat androgen-dependent diseases in women, such as acne, especially of pronounced types, and hyperandrogenic symptoms in patients with seborrhea or inflammation or nodule formation (papupustular acne, nodular cystic acne), androgenetic alopecia in women, mild hirsutism, and polycystic ovary syndrome.

Headquartered in Leverkusen, Germany, Bayer HealthCare is a subsidiary of the Bayer Group, which develops, manufactures and markets original products for the prevention, diagnosis and treatment of diseases, and is committed to improving human and animal health.

Bayer HealthCare Pharmaceuticals is one of the many divisions of Bayer HealthCare AG, whose R&D focus areas are oncology, women's healthcare, cardiology, hematology and diagnostic contrast agents.

Bayer's Healthcare Division has subsidiaries in more than 100 countries around the world, with products in more than 100 countries around the world, and its sales in 2010 reached nearly 11 billion euros. In addition, Bayer's Healthcare Division – Western Pharmaceuticals has 38,000 employees worldwide, of which more than 6,200 are R&D personnel.

In order to successfully improve the quality of life of human beings, the company is committed to the research and development of innovative pharmaceuticals and healthcare related services, while continuously improving the performance of existing products. With this in mind, Bayer Healthcare-Western Pharmacy can leverage more than 100 years of industry experience to create a healthier and better future for mankind.